Bio Nano Consulting
(BNC), the specialist bio-nanotechnology product development consultancy,
is delighted to be heading into only their second year of trading with one award
already under their belt and two further award shortlistings. In recognition
of their internationalisation, significant progress and performance as ambassadors
of the UK life science sector, BNC has been shortlisted for the Genesis Awards'
UKTI assisted newcomer of the year and Company Newsflow of the Year. Meanwhile,
Dr Rachel McKendry, one of BNC's key collaborators, recently received the prestigious
Paterson medal and prize from the Institute of Physics, in recognition of her
international contributions.
The Genesis Awards celebrate the best that the UK has to offer in biotech and
recognise the great success achieved by the UK's leading companies, universities
and inward investors over the previous 12 months. Being shortlisted for these
awards further enhances BNC's reputation as a commercially-focused consultancy
with world class technology and expertise. With their rapidly expanding portfolio
of clients in a variety of areas, including biotechnology, defence, electronics,
pharmaceutical and med-tech, the future is looking increasingly bright for BNC.
BNC's CEO, Dr David Sarphie commented "It has been a fantastic year for
BNC. We have literally gone from strength to strength with many sizable contracts
won, a 3 fold increase in turnover and expansion of our staff to 11 from just
3. To have this recognised by these prestigious organisations is a tremendous
honour."
The Genesis Awards take place at London's Queen Elizabeth Conference Centre
on the 10th December.
The BNC is a specialist research and development consultancy operating in
the convergent field of bionanotechnology. A joint venture of Imperial College
London and University College London, the BNC is funded through the Technology
Strategy Board (TSB) with additional support from the London Development Agency
(LDA).
Along with its partner organisation, the National Physical Laboratory, the
BNC offers a service to the biomedical and healthcare industries in microsystems
and nanotechnology. This encompasses design, 3-D modelling and visualisation,
rapid prototyping, and characterisation.